Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors
Enter drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) ( LXRP Profile ), which recently announced a significant breakthrough in alternative nicotine delivery technology that was first proven effective in cannabinoid or CBD delivery.
- Enter drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) ( LXRP Profile ), which recently announced a significant breakthrough in alternative nicotine delivery technology that was first proven effective in cannabinoid or CBD delivery.
- In this specific study, Lexaria's patented DehydraTECH delivery technology was analyzed for use as a new nicotine delivery method.
- The company's proprietary technology improves the delivery of bioactive compounds and has already shown to enhance the bioavailability of orally ingested cannabinoids (CBDs) derived from cannabis, while also masking taste.
- As such, it made sense to further analyze DehydraTECH's capabilities in terms of nicotine delivery.